Controlled Substances Statement
Last updated: Q1 2026. Reviewed quarterly.
1. Statement
SR Biosciences LLC does not manufacture, sell, import, or distribute any substance listed under Schedule I, II, III, IV, or V of the US Controlled Substances Act (21 U.S.C. § 801 et seq.), nor any substance listed under applicable state analog acts.
2. SR-17018 Status
SR-17018 (CAS 2134602-45-0) is not a scheduled substance under the US Controlled Substances Act as of the date of this statement. This determination is reviewed quarterly. SR Biosciences makes no representations regarding the regulatory status of SR-17018 in jurisdictions outside the United States. Customers are responsible for independently verifying the status of SR-17018 under all applicable laws in their jurisdiction.
3. Customer Responsibility
Customers are solely responsible for verifying the legal status of SR-17018 in their jurisdiction prior to placing an order. This includes, but is not limited to, federal scheduling, state analog acts, and any applicable local regulations. SR Biosciences cannot provide legal advice and no statement made by SR Biosciences should be construed as legal advice.
4. Review Schedule
This statement is reviewed on a quarterly basis. Last review: Q1 2026. Next scheduled review: Q2 2026. SR Biosciences reserves the right to suspend or discontinue sales of any product at any time in response to changes in regulatory status.
5. Contact
Compliance questions should be directed to support@srbio.com.